Pneumatic Radial Shockwave Therapy Device

[INQ. NO. 2502E09] YOUNG-IN biotech is rapidly growing in the domestic and international extracorporeal shockwave therapy (ESWT) market.
YOUNG-IN biotech is introducing its own brands to the global market – through launching ‘Thorswave,’ a pneumatic radial shockwave therapy device, and Superstar+ model equipped with a linear method that delivers shockwaves with uniform energy to a 3D focal area.
Thorswave is a treatment method optimized for pain relief and tension relief in wide areas such as muscles and fascia. This technology adopts a multi-focus method that provides a wide treatment range, so it can be effectively applied to large surface areas.
In particular, it minimizes noise during the treatment process by implementing a built-in low-noise pneumatic system, providing a comfortable environment for both patients and medical staff.
These technical features increase usability in various environments of medical facilities and further improve the treatment experience for patients. In addition, it supports various applicators suitable for various treatment areas, providing precise and customized treatment according to specific areas.
This allows for wide-ranging treatment from the surface layer to deep layers of tissues, as well as muscles and fascia, and maximizes the therapeutic effects.
Thorswave has established itself as an innovative treatment solution that satisfies various clinical needs, such as musculoskeletal diseases, sports injuries, and chronic pain management, through these features.
Thorswave has obtained domestic medical device product approval, officially acknowledging its safety and quality. In addition, it has an internationally recognized CB Report, proving the reliability and competitiveness of its products in the global market. YOUNG-IN biotech is also planning to receive overseas certification in the future as a CE MDR version.

 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods